Ricci, Caterina
 Distribuzione geografica
Continente #
EU - Europa 901
NA - Nord America 738
AS - Asia 326
SA - Sud America 55
AF - Africa 7
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.030
Nazione #
US - Stati Uniti d'America 728
IT - Italia 283
DE - Germania 211
SG - Singapore 117
SE - Svezia 107
CN - Cina 93
FR - Francia 54
PL - Polonia 53
BR - Brasile 50
IN - India 38
GB - Regno Unito 35
IE - Irlanda 34
UA - Ucraina 30
ID - Indonesia 25
FI - Finlandia 24
RU - Federazione Russa 20
HK - Hong Kong 15
KR - Corea 13
NL - Olanda 13
AT - Austria 11
BE - Belgio 10
CA - Canada 7
IR - Iran 6
RO - Romania 4
TR - Turchia 4
VN - Vietnam 4
ES - Italia 3
IL - Israele 3
MA - Marocco 3
AU - Australia 2
AW - Aruba 2
CH - Svizzera 2
CI - Costa d'Avorio 2
EC - Ecuador 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
BG - Bulgaria 1
DK - Danimarca 1
EG - Egitto 1
EU - Europa 1
GE - Georgia 1
GR - Grecia 1
HU - Ungheria 1
IQ - Iraq 1
JP - Giappone 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LT - Lituania 1
MO - Macao, regione amministrativa speciale della Cina 1
MT - Malta 1
MX - Messico 1
PE - Perù 1
SK - Slovacchia (Repubblica Slovacca) 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 2.030
Città #
Chandler 131
Ashburn 100
Singapore 88
Warsaw 53
Rome 49
Dublin 34
Ann Arbor 28
Milan 28
New York 28
Hyderabad 26
Jacksonville 25
Jakarta 25
San Mateo 21
Fairfield 20
The Dalles 20
Helsinki 16
Houston 16
Marseille 16
Wilmington 15
Bremen 13
Moscow 13
Nürnberg 13
Dearborn 12
Los Angeles 12
Redwood City 12
Hefei 11
Hong Kong 11
Düsseldorf 10
Nanjing 10
Pescara 10
Woodbridge 10
Boston 9
Brussels 9
Cambridge 9
Frankfurt am Main 9
Princeton 9
Seoul 9
Munich 7
Seattle 7
Washington 7
Beijing 6
London 6
Paris 6
Toronto 6
Vienna 6
Busto Arsizio 5
Cattolica 5
Portsmouth 5
Detroit 4
Lancaster 4
Mcallen 4
New Haven 4
Nuremberg 4
Pisa 4
Ribeirão Preto 4
Allumiere 3
Amsterdam 3
Asti 3
Baronissi 3
Boardman 3
Changsha 3
Chicago 3
Dong Ket 3
Giulianova 3
Izmir 3
Jeju City 3
Lauterbourg 3
Lawrence 3
Norwalk 3
Pavia 3
San Diego 3
San Jose 3
Santa Clara 3
Shanghai 3
Shenyang 3
Abidjan 2
Agropoli 2
Andover 2
Augusta 2
Bari 2
Belo Horizonte 2
Brooklyn 2
Bucharest 2
Buffalo 2
Chennai 2
Chongqing 2
Crispano 2
Edinburgh 2
Guangzhou 2
Guidonia Montecelio 2
Jasper 2
Juiz de Fora 2
Kunming 2
Lecco 2
Macerata 2
Mountain View 2
Nanchang 2
Nave 2
North Bergen 2
Oranjestad 2
Totale 1.134
Nome #
NEOPLASIE DELLA VULVA E DELLA VAGINA 266
Clinical utility of trabectedin for the treatment of ovarian cancer: current evidence 265
Quality of life and psychological distress in locally advanced cervical cancer patients administered pre-operative chemoradiotherapy 153
Vascular involvement in inflammatory bowel disease: pathogenesis and clinical aspects. 144
Clinical performance of human papillomavirus E6 and E7 mRNA testing for high-grade lesions of the cervix. 119
Neoadjuvant chemotherapy followed by conization in stage IB2–IIA1 cervical cancer larger than 2 cm: a pilot study 114
Chemotherapy resistance in epithelial ovarian cancer: Mechanisms and emerging treatments 91
Hpv and cytology testing in women undergoing 9-valent hpv opportunistic vaccination: A single-cohort follow up study 81
Locally Advanced Cervical Cancer in Pregnancy 79
Real-world management of trabectedin/pegylated liposomal doxorubicin in platinum-sensitive recurrent ovarian cancer patients: A national survey 76
Cancer and Mediterranean Diet: A Review 72
Intestinal Permeability and Dysbiosis in Female Patients with Recurrent Cystitis: A Pilot Study 63
Final results from GCIG/ENGOT/AGO-OVAR 12, a randomised placebo-controlled phase III trial of nintedanib combined with chemotherapy for newly diagnosed advanced ovarian cancer 59
Health utilities lost and risk factors associated with HPV-induced diseases in men and women: The HPV Italian collaborative study group 58
Survival outcomes in patients with BRCA mutated, variant of unknown significance, and wild type ovarian cancer treated with PARP inhibitors 51
PARP Inhibitors Resistance: Mechanisms and Perspectives 48
Recent progress in the use of pharmacotherapy for endometrial cancer 46
Advanced and recurrent endometrial cancer: State of the art and future perspectives 43
Combining PARP inhibition and immune checkpoint blockade in ovarian cancer patients: a new perspective on the horizon? 40
Are we facing a new colposcopic practice in the HPV vaccination era? Opportunities, challenges, and new perspectives 38
Long-term efficacy and safety of human papillomavirus vaccination 37
Preclinical and Clinical Evidence of Lurbinectedin in Ovarian Cancer: Current Status and Future Perspectives 36
Colposcopy Accuracy and Diagnostic Performance: A Quality Control and Quality Assurance Survey in Italian Tertiary-Level Teaching and Academic Institutions—The Italian Society of Colposcopy and Cervico-Vaginal Pathology (SICPCV) 34
Survival outcomes in patients with BRCA mutated, variant of unknown significance, and wild type ovarian cancer treated with PARP inhibitors 29
Survival outcomes in patients with BRCA mutated, variant of unknown significance, and wild type ovarian cancer treated with PARP inhibitors 27
Totale 2.069
Categoria #
all - tutte 9.667
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.667


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202029 0 0 0 0 0 0 0 0 0 0 18 11
2020/2021181 6 13 5 16 23 5 16 2 17 12 51 15
2021/2022175 17 8 5 12 6 10 3 25 7 18 18 46
2022/2023449 48 56 22 64 21 63 23 30 62 17 30 13
2023/2024325 13 52 24 27 10 47 40 13 9 10 26 54
2024/2025503 24 6 61 22 47 24 35 21 65 105 93 0
Totale 2.069